BioFrank, who joined Ampersand as an Operating Partner in 2016, serves as Chairman of Gyros Protein Technologies. Frank most recently served as CEO of Affymetrix, a leading provider of genomics and cell biology products that was sold in 2016 for $1.3 billion. Previously, Frank was CEO of Dionex, a leading provider of analytical instrumentation that was sold in 2011 for $2.1 billion. He also held senior executive positio ....
Education
Degrees
Start Free Trial
Access "Frank R. Witney" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any) in one connected platform (AcquityData).